Daniel Krauss
Radiation Oncology · Royal Oak, MINPI 1275593972
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,463 of the $7,078 with a category attached, or 77.2%. 9 manufacturers reported payments, led by Sanofi at 54.9% of the total. Among radiation oncology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $393.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- Blue Earth Diagnostics$2K
- Theragenics Corporation$607
- Boston Scientific$237
- Arrow International, Inc.$144
- Elekta, Inc.$132
- plus $154 from 3 others
Across 14 payments — averaging $3760.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$53K
What the payments were for
- Consulting fees$5,46377%
- Food & beverage$1,58722%
- Entertainment$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $3,888 |
| Blue Earth Diagnostics | 4 | $1,916 |
| Theragenics Corporation | 3 | $607 |
| Boston Scientific | 3 | $237 |
| Arrow International, Inc. | 1 | $144 |
| Elekta, Inc. | 2 | $132 |
| Siemens Medical Solutions USA, Inc. | 1 | $97 |
| Myovant Sciences Inc. | 1 | $31 |
| Johnson & Johnson | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JEVTANA$1,944
- LIBTAYO$1,944
- POSLUMA$1,863
- SpaceOAR VUE System - 10mL$170
- FLEXITRON HDR$104
How this compares
$7,078 in reported general payments places this provider in the 90th percentile of 198 radiation oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 207 | $3,801 |
| Megestrol Acetate | 20 | $544 |
| Omeprazole | 32 | $100 |
| Ibuprofen | 32 | $90 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Royal Oak
- Craig StevensRoyal Oak$11K
- Hong-Yiou LinRoyal Oak$3K
- Inga GrillsRoyal Oak$3K
- Benjamin WillenRoyal Oak$1K
- Peter ChenRoyal Oak$1K
- Frank ViciniPontiac$231K
- Thomas BoikeClarkston$171K
- Farzan SiddiquiDetroit$72K
- Daniel WahlAnn Arbor$42K
- Daniel ChangAnn Arbor$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.